Literature DB >> 12369878

The cyanobacterial origin of potent anticancer agents originally isolated from sea hares.

H Luesch1, G G Harrigan, G Goetz, F D Horgen.   

Abstract

It is increasingly evident that the true biological origin of many metabolites originally isolated from certain marine macroorganisms is cyanobacterial. For example, several dolastatins, potent cytotoxic compounds originally derived from the sea hare Dolabella auricularia, have now been isolated from marine cyanobacteria of the genera Lyngbya and Symploca. This review discusses the isolation of dolastatins and close structural analogues from cyanobacteria. Biosynthetic signatures of metabolites isolated from sea hares, but which are most probably cyanobacterial in origin, are also presented. Finally, some more complex ecology involving movement of cyanobacterial metabolites through the marine food web is presented.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12369878     DOI: 10.2174/0929867023369051

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  19 in total

1.  Diversity of monomers in nonribosomal peptides: towards the prediction of origin and biological activity.

Authors:  Ségolène Caboche; Valérie Leclère; Maude Pupin; Gregory Kucherov; Philippe Jacques
Journal:  J Bacteriol       Date:  2010-08-06       Impact factor: 3.490

2.  Antineoplastic agents. 545. Isolation and structure of turbostatins 1-4 from the Asian marine mollusk Turbo stenogyrus.

Authors:  George R Pettit; Yuping Tang; John C Knight
Journal:  J Nat Prod       Date:  2005-07       Impact factor: 4.050

Review 3.  Biological targets and mechanisms of action of natural products from marine cyanobacteria.

Authors:  Lilibeth A Salvador-Reyes; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2015-03       Impact factor: 13.423

Review 4.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

Review 5.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

6.  Characterization of PPTNs, a cyanobacterial phosphopantetheinyl transferase from Nodularia spumigena NSOR10.

Authors:  J N Copp; A A Roberts; M A Marahiel; B A Neilan
Journal:  J Bacteriol       Date:  2007-02-16       Impact factor: 3.490

Review 7.  Immense essence of excellence: marine microbial bioactive compounds.

Authors:  Ira Bhatnagar; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2010-10-15       Impact factor: 5.118

8.  Dolastatin 15 from a Marine Cyanobacterium Suppresses HIF-1α Mediated Cancer Cell Viability and Vascularization.

Authors:  Ranjala Ratnayake; Sarath P Gunasekera; Jia Jia Ma; Long H Dang; Thomas J Carney; Valerie J Paul; Hendrik Luesch
Journal:  Chembiochem       Date:  2020-05-12       Impact factor: 3.164

Review 9.  Cyanobacterial toxins as allelochemicals with potential applications as algaecides, herbicides and insecticides.

Authors:  John P Berry; Miroslav Gantar; Mario H Perez; Gerald Berry; Fernando G Noriega
Journal:  Mar Drugs       Date:  2008-05-15       Impact factor: 5.118

10.  Comparative genomics analysis of NtcA regulons in cyanobacteria: regulation of nitrogen assimilation and its coupling to photosynthesis.

Authors:  Zhengchang Su; Victor Olman; Fenglou Mao; Ying Xu
Journal:  Nucleic Acids Res       Date:  2005-09-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.